The protein IgG Chain C, a vital component of the immune system, plays a central role in the body's defense mechanisms. It is one of the constant regions of the immunoglobulin G (IgG) molecule, the most abundant type of antibody found in blood circulation and extracellular fluid. Antibodies are produced by the immune system in response to antigens, which are substances recognized as foreign. The IgG Chain C region is crucial for the antibody's effector functions, including binding to various immune cells and activating the complement system, which is a group of proteins that assists in eliminating pathogens. The expression of IgG Chain C is a tightly regulated process within the immune system, typically occurring after B cells, a type of white blood cell, have been activated. Upon activation, these B cells can differentiate into plasma cells that produce antibodies with the specific IgG Chain C region, tailored to recognize and bind to a particular antigen.
Various chemical compounds have been identified that can potentially influence the expression of IgG Chain C. For instance, certain adjuvants used in research, such as Freund's adjuvant, can enhance the immune response, which might lead to increased production of antibodies, including those with the IgG Chain C region. Similarly, compounds like phorbol 12-myristate 13-acetate (PMA) are known to activate protein kinase C, a key signal transduction molecule in cells. Activation of protein kinase C can lead to a cascade of cellular events resulting in the differentiation of B cells into plasma cells and the subsequent upregulation of IgG Chain C expression. Other substances, such as CpG methylation inhibitors, can epigenetically modify the expression of genes involved in the immune response, which may include genes coding for the IgG Chain C region. Additionally, synthetic compounds such as imidazoquinolines, which can stimulate the immune system through toll-like receptor pathways, could also impact the level of IgG Chain C expression. It is essential to understand that while these compounds can affect the expression of IgG Chain C, their exact mechanisms of action and the outcomes of such interactions are complex and subject to ongoing research in the field of immunology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is known to activate protein kinase C, leading to the activation of transcription factors that upregulate the production of IgG Chain C by promoting the differentiation of B cells into plasma cells. | ||||||
β-Mercaptoethanol | 60-24-2 | sc-202966A sc-202966 | 100 ml 250 ml | $90.00 $120.00 | 10 | |
In cell culture, β-Mercaptoethanol can break disulfide bonds, which may contribute to a more reducing environment that fosters B-cell proliferation and induces higher expression levels of IgG Chain C. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
Gardiquimod, as a synthetic ligand for TLR7, can initiate a signaling cascade that leads to the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), which in turn may stimulate the expression of IgG Chain C. | ||||||
Diethylstilbestrol | 56-53-1 | sc-204720 sc-204720A sc-204720B sc-204720C sc-204720D | 1 g 5 g 25 g 50 g 100 g | $71.00 $287.00 $547.00 $1098.00 $2185.00 | 3 | |
Diethylstilbestrol might have a role in stimulating the maturation and proliferation of B cells, thereby potentially increasing the production of IgG Chain C in response to antigenic stimulation. | ||||||